TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
ErGe BioTech AB
Closing information (x1000 EUR)
Closing information | 2023/04 | 2022/04 | 2021/04 |
Turnover |
126
|
127
|
133 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
45
|
44
|
47 |
EBITDA |
45
|
44
|
47 |
Total assets |
162
|
145
|
120 |
Current assets |
71
|
45
|
33 |
Current liabilities |
15
|
22
|
29 |
Equity capital |
136
|
111
|
87 |
- share capital |
4
|
5
![]() |
5 |
Employees (average) |
1
|
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Solvency |
84.0%
|
76.6%
|
72.5% |
Turnover per employee |
126
|
64
|
66 |
Profit as a percentage of turnover |
35.7%
|
34.6%
|
35.3% |
Return on assets (ROA) |
27.8%
|
30.3%
|
39.2% |
Current ratio |
473.3%
|
204.5%
|
113.8% |
Return on equity (ROE) |
33.1%
|
39.6%
|
54.0% |
Change turnover |
11
|
-4
|
4 |
Change turnover % |
9%
|
-3%
|
3% |
Chg. No. of employees |
-1
|
0
![]() |
0 |
Chg. No. of employees % |
-50%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/04 | 2022/04 | 2021/04 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.